{
    "2021-05-27": [
        [
            {
                "time": "2021-05-27",
                "original_text": "药企观察 | 不断前进中的无菌仿制药巨头-印度Gland Pharma",
                "features": {
                    "keywords": [
                        "药企",
                        "无菌仿制药",
                        "印度",
                        "Gland Pharma"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-27",
                "original_text": "A股早报2021年5月27日星期四",
                "features": {
                    "keywords": [
                        "A股",
                        "早报"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-26",
                "original_text": "A股融资融券日报：两融余额增加50.37亿元（5月26日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-27",
                "original_text": "今日MSCI再迎重要时间点",
                "features": {
                    "keywords": [
                        "MSCI",
                        "时间点"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-27",
                "original_text": "32家私募豪赌“红筹”药股，营收为零的海创药业如何突入科创板？",
                "features": {
                    "keywords": [
                        "私募",
                        "红筹",
                        "药股",
                        "海创药业",
                        "科创板"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}